ALX Oncology (ALXO) Institutional Ownership $1.96 -0.04 (-1.75%) As of 01:05 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for ALX Oncology (NASDAQ:ALXO)CurrentInstitutional OwnershipPercentage97.97%Number ofInstitutional Buyers(last 12 months)13TotalInstitutional Inflows(last 12 months)$24.60MNumber ofInstitutional Sellers(last 12 months)9TotalInstitutional Outflows(last 12 months)$1.99M Get ALXO Insider Trade Alerts Want to know when executives and insiders are buying or selling ALX Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data ALXO Institutional Buying and Selling by Quarter ALX Oncology Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2026Bank of America Corp DE577,783$1.16M0.0%+8.6%0.429% 5/18/2026 Redmile Group LLC7,964,188$15.97M1.1%+143.9%5.919% 5/16/2026 venBio Partners LLC12,884,638$25.83M9.2%+32.8%9.575% 5/16/2026 Orbimed Advisors LLC2,866,256$5.75M0.1%N/A2.130% 5/15/2026 OMERS ADMINISTRATION Corp75,000$150K0.0%N/A0.056% 5/14/2026 Renaissance Technologies LLC732,599$1.47M0.0%+73.2%0.544% 2/26/2026 Seven Fleet Capital Management LP117,817$133K0.1%N/A0.217% 2/18/2026 Bridgeway Capital Management LLC76,072$86K0.0%+111.3%0.140% 2/13/2026 Marshall Wace LLP26,376$30K0.0%-33.4%0.049% 2/13/2026 State Street Corp124,228$140K0.0%+11.0%0.229% Get the Latest News and Ratings for ALXO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ALX Oncology and its competitors with MarketBeat's FREE daily newsletter. 2/12/2026 Renaissance Technologies LLC423,099$478K0.0%+157.2%0.780% 1/1/2026 JPMorgan Chase & Co.61,899$113K0.0%-29.9%0.114% 11/17/2025 Qube Research & Technologies Ltd16,946$31K0.0%-61.6%0.031% 11/17/2025Bank of America Corp DE530,828$971K0.0%-48.7%0.979% 11/17/2025 Ameriprise Financial Inc.652,897$1.20M0.0%N/A1.204% 11/14/2025 Two Sigma Investments LP606,671$1.11M0.0%+26.9%1.119% 11/14/2025 Bridgeway Capital Management LLC36,000$66K0.0%N/A0.066% 11/7/2025Vanguard Group Inc.1,528,619$2.80M0.0%-4.5%2.855% 11/7/2025 JPMorgan Chase & Co.61,899$113K0.0%-29.9%0.116% 8/15/2025Bank of America Corp DE1,035,127$430K0.0%-28.7%1.933% 8/14/2025 Jane Street Group LLC203,266$84K0.0%N/A0.381% 8/14/2025 Redmile Group LLC3,391,455$1.41M0.1%-6.8%6.352% 8/13/2025 Marshall Wace LLP106,280$45K0.0%-60.8%0.199% 8/12/2025 XTX Topco Ltd74,770$31K0.0%-19.0%0.140% 8/12/2025 JPMorgan Chase & Co.88,352$37K0.0%-75.3%0.165% 8/8/2025 Geode Capital Management LLC315,421$131K0.0%-59.1%0.591% 6/27/2025 Goldman Sachs Group Inc.373,214$233K0.0%-34.4%0.699% 5/21/2025Acadian Asset Management LLC1,296,331$806K0.0%+16.8%2.428% 5/16/2025Goldman Sachs Group Inc.373,214$233K0.0%-34.4%0.699% 5/16/2025AQR Capital Management LLC119,050$74K0.0%+183.6%0.223% 5/16/2025Almitas Capital LLC1,353,141$843K0.3%+10.6%2.534% 5/15/2025Redmile Group LLC3,640,834$2.27M0.2%-1.3%6.819% 5/15/2025MPM Bioimpact LLC550,000$343K0.1%-60.5%1.030% 5/12/2025Nuveen LLC164,790$103K0.0%N/A0.309% 5/12/2025Invesco Ltd.73,836$46K0.0%N/A0.138% 5/8/2025XTX Topco Ltd92,259$57K0.0%-65.0%0.173% 2/17/2025Two Sigma Investments LP704,131$1.18M0.0%+6.7%1.335% 2/17/2025Two Sigma Advisers LP823,900$1.38M0.0%+64.6%1.562% 2/17/2025Tang Capital Management LLC3,296,883$5.51M0.4%-21.6%6.251% 2/17/2025Redmile Group LLC3,689,611$6.16M0.4%-3.8%6.996% The 1934 playbook (Ad)In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it coming — but those who did walked away wealthy.Trump holds that same legal authority today. Advisors close to the administration believe he may use it.If he does, the transfer moves fast. The window to position yourself on the right side is already closing.Get the free report now2/17/2025MPM Bioimpact LLC1,391,434$2.32M0.3%-42.3%2.638% 2/17/2025Nuveen Asset Management LLC164,790$275K0.0%+55.6%0.312% 2/17/2025Deutsche Bank AG101,113$169K0.0%+521.0%0.192% 2/17/2025D. E. Shaw & Co. Inc.255,878$427K0.0%-11.9%0.485% 2/17/2025Cubist Systematic Strategies LLC32,021$53K0.0%-91.7%0.061% 2/17/2025Bridgeway Capital Management LLC75,000$125K0.0%N/A0.142% 2/17/2025Bank of America Corp DE1,035,326$1.73M0.0%+492.9%1.963% 2/17/2025Almitas Capital LLC1,222,945$2.04M0.4%N/A2.319% 2/14/2025Northern Trust Corp343,066$573K0.0%+7.3%0.650% 2/14/2025Dimensional Fund Advisors LP26,233$44K0.0%-30.3%0.050% 2/13/2025XTX Topco Ltd263,856$441K0.0%-16.8%0.500% 2/13/2025Bank of Nova Scotia105,306$176K0.0%N/A0.200% 2/13/2025Bank of Montreal Can826,582$1.38M0.0%N/A1.567% 2/12/2025Geode Capital Management LLC740,106$1.24M0.0%+5.6%1.403% 2/12/2025JPMorgan Chase & Co.236,046$394K0.0%+476.7%0.448% 2/11/2025Sei Investments Co.60,795$102K0.0%N/A0.115% 2/6/2025Charles Schwab Investment Management Inc.216,707$362K0.0%-3.8%0.411% 2/4/2025Los Angeles Capital Management LLC301,419$503K0.0%+16.9%0.572% 2/4/2025Bank of New York Mellon Corp90,003$150K0.0%+12.0%0.171% 1/29/2025JSF Financial LLC17,500$29K0.0%N/A0.033% 11/19/2024Barclays PLC59,502$107K0.0%+243.6%0.113% 11/15/2024Barclays PLC59,502$107K0.0%+243.6%0.113% 11/15/2024XTX Topco Ltd317,322$578K0.0%N/A0.602% 11/15/2024Jane Street Group LLC27,918$51K0.0%-64.3%0.053% 11/15/2024Wellington Management Group LLP167,831$305K0.0%+15.2%0.318% 11/15/2024State Street Corp671,376$1.22M0.0%-4.8%1.273% 11/15/2024Redmile Group LLC3,836,576$6.98M0.4%-5.0%7.274% 11/14/2024Verition Fund Management LLC133,025$242K0.0%+308.4%0.252% 11/14/2024Walleye Capital LLC230,875$420K0.0%+110.3%0.438% 11/13/2024FMR LLC5,865,106$10.67M0.0%-25.0%11.121% 11/12/2024Charles Schwab Investment Management Inc.225,302$410K0.0%-4.5%0.428% 11/8/2024Connor Clark & Lunn Investment Management Ltd.83,042$151K0.0%+207.4%0.158% 11/5/2024GSA Capital Partners LLP48,204$88K0.0%N/A0.092% 11/4/2024Los Angeles Capital Management LLC257,779$469K0.0%N/A0.489% 11/2/2024Privium Fund Management B.V.509,059$926K0.2%+28.2%0.967% 10/3/2024SG Americas Securities LLC27,394$50K0.0%+33.6%0.053% 8/19/2024Point72 Asset Management L.P.304,100$1.83M0.0%N/A0.584% 8/16/2024Algert Global LLC41,215$249K0.0%N/A0.079% 8/15/2024Susquehanna Portfolio Strategies LLC73,468$443K0.0%-19.2%0.141% 8/15/2024The Manufacturers Life Insurance Company13,662$82K0.0%-77.3%0.026% 8/15/2024AQR Capital Management LLC18,079$109K0.0%+50.7%0.035% 8/14/2024Cubist Systematic Strategies LLC199,441$1.20M0.0%N/A0.383% 8/14/2024Marshall Wace LLP635,679$3.83M0.0%+423.0%1.220% 8/12/2024Inspire Investing LLC58,707$354K0.0%+77.1%0.113% 8/12/2024Hsbc Holdings PLC10,780$63K0.0%N/A0.021% 8/9/2024Renaissance Technologies LLC438,200$2.64M0.0%+87.2%0.841% 8/9/2024Dimensional Fund Advisors LP34,543$208K0.0%-31.4%0.066% 8/8/2024American Century Companies Inc.23,685$143K0.0%-20.2%0.045% 8/6/2024Quest Partners LLC20,781$125K0.0%-17.0%0.040% 8/1/2024Rhumbline Advisers55,220$333K0.0%+10.8%0.106% $30 stock to buy before Starlink goes public (WATCH NOW!) (Ad)A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker.Watch the free video to get the ticker today.8/1/2024Privium Fund Management B.V.396,966$2.27M0.6%N/A0.762% 7/29/2024Zurcher Kantonalbank Zurich Cantonalbank6,517$39K0.0%+394.8%0.013% 7/26/2024Bank of New York Mellon Corp104,966$633K0.0%+31.6%0.201% 7/12/2024SG Americas Securities LLC20,506$124K0.0%-14.2%0.039% 5/16/2024California State Teachers Retirement System22,797$254K0.0%+413.8%0.044% 5/16/2024Redmile Group LLC4,326,509$48.24M1.8%+18.2%8.304% 5/15/2024Price T Rowe Associates Inc. MD232,769$2.60M0.0%-57.2%0.447% 5/14/2024EntryPoint Capital LLC2,847$32K0.0%N/A0.005% 5/14/2024CANADA LIFE ASSURANCE Co2,379$27K0.0%N/A0.005% 5/10/2024Vanguard Group Inc.1,566,464$17.47M0.0%+4.3%3.133% ALXO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ALXO shares? During the previous two years, 59 institutional investors and hedge funds held shares of ALX Oncology. The most heavily invested institutionals were venBio Partners LLC ($25.83M), Redmile Group LLC ($15.97M), FMR LLC ($10.67M), Orbimed Advisors LLC ($5.75M), Tang Capital Management LLC ($5.51M), Vanguard Group Inc. ($2.80M), and Point72 Asset Management L.P. ($1.83M).Learn more on ALX Oncology's institutional investors. What percentage of ALX Oncology's stock is owned by institutional investors? 97.97% of ALX Oncology's stock is owned by institutional investors. Learn more on ALXO's institutional investor holdings. Which institutional investors have been buying ALX Oncology's stock? Of the 46 institutional investors that purchased ALX Oncology's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Redmile Group LLC ($4.70M), venBio Partners LLC ($3.18M), Orbimed Advisors LLC ($2.87M), Almitas Capital LLC ($1.35M), Bank of America Corp DE ($906.64K), Bank of Montreal Can ($826.58K), and Renaissance Technologies LLC ($772.20K). How much institutional buying is happening at ALX Oncology? Institutional investors have bought a total of 12,817,449 shares in the last 24 months. This purchase volume represents approximately $24.60M in transactions. Which of ALX Oncology's major shareholders have been selling company stock? Of the 9 institutional investors that sold ALX Oncology's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Bank of America Corp DE ($920.95K), Geode Capital Management LLC ($455.49K), JPMorgan Chase & Co. ($322.51K), Redmile Group LLC ($249.38K), Goldman Sachs Group Inc. ($195.80K), Marshall Wace LLP ($178.12K), and Vanguard Group Inc. ($72.19K). How much institutional selling is happening at ALX Oncology? Institutional investors have sold a total of 2,439,110 shares in the last 24 months. This volume of shares sold represents approximately $1.99M in transactions. Related Companies DBV Technologies Institutional Ownership Evotec Institutional Ownership Septerna Institutional Ownership Savara Institutional Ownership CureVac Institutional Ownership Alvotech Institutional Ownership Phathom Pharmaceuticals Institutional Ownership Schrodinger Institutional Ownership Cronos Group Institutional Ownership Xencor Institutional Ownership This page (NASDAQ:ALXO) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALX Oncology Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ALX Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
